课题基金 / 基金详情

Effects of insulin-dependent diabetes resistance alleles on CD8 tolerance in NOD

Effects of insulin-dependent diabetes resistance alleles on CD8 tolerance in NOD
胰岛素依赖性糖尿病抵抗等位基因对 NOD 中 CD8 耐受性的影响
批准号:
7134119
负责人:
LINDA A SHERMAN
金额:
$72.98万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-15 至 2011-08-31

项目摘要

项目成果

LINDA A SHERMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): NOD mice spontaneously develop Type 1 Diabetes (T1D) due to a loss of T cell tolerance to islet antigens. Congenic strains of NOD mice that are highly protected from the occurrence of T1D, because they have multiple resistance alleles situated on two chromosomes (ldd3/5 mice) or 3 linked resistance alleles on a single chromosome (Idd9), do not harbor high-avidity, islet-specific CDS T cells. In order to delineate the mechanism by which CDS tolerance is restored, we will trace the path of naive, islet-specific CDS cells in situations where resistance alleles at multiple or single Idd loci are expressed only in particular cell types. This will provide an assay that will identify the cell(s) that must express specific protective Idd genes to achieve CDS tolerance. We will then correlate gene expression of candidate Idd genes within the relevant cell populations obtained from NOD or congenic mice with the functional consequences that relate to protection from autoimmunity. Although four of the subregions, Idd3, Idd5.1, Idd5.2 and Idd9.3 are relatively well-characterized and the likely molecular basis of disease susceptibility is known in each case, Idd5.3, Idd9.2, and Idd9.1 require further efforts to positionally clone the Idd genes. Relevance: The occurrence of T1D in humans and mice has been mapped to a number of genetic susceptibility loci that prevent T cell tolerance to islet antigens. By elucidating naturally occurring mechanisms that restore such tolerance (as defined by Idd genes that prevent disease), we will better understand the etiology of the disease and also identify targets for interventions that can be used to prevent T1D.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PTPN22 R619W in NOD mice
  • 批准号:
    10183146
  • 项目类别:
  • 资助金额:
    $74.52万
  • 财政年份:
    2017
  • 负责人:
    LINDA A SHERMAN
  • 依托单位:
PTPN22 R619W in NOD mice
  • 批准号:
    9307520
  • 项目类别:
  • 资助金额:
    $76.27万
  • 财政年份:
    2017
  • 负责人:
    LINDA A SHERMAN
  • 依托单位:
Creating Mouse Models to Study the Link Betwee PTPN22 and ACPA+ RA
  • 批准号:
    9300832
  • 项目类别:
  • 资助金额:
    $21.18万
  • 财政年份:
    2016
  • 负责人:
    LINDA A SHERMAN
  • 依托单位:
Mutant PTPN22 in autoimmune mice
  • 批准号:
    9095202
  • 项目类别:
  • 资助金额:
    $14.44万
  • 财政年份:
    2015
  • 负责人:
    LINDA A SHERMAN
  • 依托单位:
国内基金
海外基金
精神分裂症脑网络异常的影像遗传学研究
  • 批准号:
    81000582
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2010
  • 负责人:
    刘冰
  • 依托单位:
孤独症全基因组关联第二阶段研究
  • 批准号:
    81071110
  • 项目类别:
    面上项目
  • 资助金额:
    32.0万元
  • 批准年份:
    2010
  • 负责人:
    王力芳
  • 依托单位:
孤独症与突触发育相关候选基因的关联研究
  • 批准号:
    30870897
  • 项目类别:
    面上项目
  • 资助金额:
    50.0万元
  • 批准年份:
    2008
  • 负责人:
    张岱
  • 依托单位:
用dsDNA微阵列筛选NF-κB DNA靶点及靶基因
  • 批准号:
    60871014
  • 项目类别:
    面上项目
  • 资助金额:
    35.0万元
  • 批准年份:
    2008
  • 负责人:
    王进科
  • 依托单位: